semaglutide heart failure reduced ejection fraction The Cardioprotective Effects of Exceed Those of Dietary Weight Loss in Mice With HFpEF Semaglutide And Clinical Outcomes In

For additional ways to make re:vitalize work for your holistic health and wellness goals, check out our virtual weight loss programs and employer weight loss programs

Many third-party plans do not cover weight-loss medications in the absence of another indicated diagnosis, making affordability a significant barrier to patients

Dempsey is a world renowned expert in complex multi-system diseases and the founder of the AIM Center for Personalized Medicine in Purchase, New York

Interventions The GLP-1 RA semaglutide (0.5 mg followed by 1 mg) (Ozempyc, Novo Nordisk A/S Bagsvaerd, Denmark) or placebo will be administered once weekly as subcutaneous injections in the abdomen or thigh

Both are injected once weekly

Broadening treatment options, especially with an oral formulation, can help reach more patients, reduce barriers to care, and support long-term management of obesity and cardiovascular disease